| scholarly article | Q13442814 |
| P50 | author | José A Luchsinger | Q56460144 |
| P2093 | author name string | Steven Shea | |
| José A Luchsinger | |||
| Charles Knirsch | |||
| Ariel Pablos-Méndez | |||
| Daniel Rabinowitz | |||
| P2860 | cites work | Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 |
| The epidemiology and significance of Chlamydia pneumoniae | Q35820707 | ||
| In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae | Q35885610 | ||
| Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline | Q37093492 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study | Q37875542 | ||
| Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women | Q37877649 | ||
| Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae | Q37878008 | ||
| Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study | Q37878104 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
| Chlamydia infections and heart disease linked through antigenic mimicry | Q37878963 | ||
| Antibiotics and risk of subsequent first-time acute myocardial infarction | Q37879181 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease | Q37882557 | ||
| Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment | Q37886087 | ||
| Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
| Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae | Q37888465 | ||
| Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 | ||
| Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
| Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease | Q37894988 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project | Q41215745 | ||
| Secondary prevention antibiotic treatment trials for coronary artery disease | Q43426369 | ||
| Infections and atherosclerosis: new clues from an old hypothesis? | Q53565811 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| antibiotic | Q12187 | ||
| P304 | page(s) | 18-21 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Relation of antibiotic use to risk of myocardial infarction in the general population | |
| P478 | volume | 89 |
| Q37863427 | Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction |
| Q38165749 | Bilateral leg edema in an older woman |
| Q34505074 | Characterization of biofilm formed by human-derived nanoparticles |
| Q58110586 | Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis |
| Q37320829 | Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis |
| Q35688156 | Macrolide antibiotics: current and future uses |
| Q36342810 | Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis. |
| Q36197442 | Optimal use of available claims to identify a Medicare population free of coronary heart disease |
| Q88248631 | Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides |
Search more.